Market Review: March 25, 2026
US Stocks 2026-03-26 08:11 source ↗

Market Review: March 25, 2026

Closing Recap

Index Up/Down % Change Last
DJ Industrials 304.66 0.66% 46,428
S&P 500 35.61 0.54% 6,591
Nasdaq 167.93 0.77% 21,929
Russell 2000 30.96 1.24% 2,536

Market Overview

U.S. stocks opened higher and maintained gains throughout the day, despite a narrow trading range. Investors are closely monitoring developments regarding Iran and the Strait of Hormuz. Ten out of eleven S&P sectors finished higher, with only the Energy sector declining. Late in the day, White House press secretary Karoline Leavitt warned that the U.S. would respond strongly to Iran if a deal is not reached, indicating a tense atmosphere in the markets.

U.S./Iran Negotiations

The U.S. presented Iran with a 15-point plan aimed at resolving the ongoing conflict, which includes demands for the dismantling of nuclear capabilities and cessation of support for proxy groups. Iran rejected this proposal, instead outlining five conditions for peace, including a halt to aggression and international recognition of its rights over the Strait of Hormuz.

Market Reactions

ARM shares surged following the announcement of its plans to sell its own semiconductor chips. The volatility index (VIX) has remained elevated, indicating market uncertainty primarily driven by geopolitical tensions. Precious metals rebounded, while Treasury yields fell in response to potential progress in peace talks.

Economic Data

February import prices rose by 1.3%, exceeding expectations, while export prices also increased. This data reflects ongoing inflationary pressures in the economy.

Sector Highlights

Autos

General Motors received an upgrade, with analysts optimistic about future growth driven by new product launches and cost reductions.

Retail

Retailers like Chewy reported mixed earnings, with revenue growth but missed expectations. The beauty sector faced challenges due to geopolitical tensions affecting sales.

Energy

Energy stocks were influenced by the ongoing conflict in the Middle East, with some companies receiving upgrades based on expected demand for U.S. liquefied petroleum gas.

Biotech & Pharma

Several biotech firms reported significant developments, including successful trials and FDA approvals, which positively impacted their stock prices.

Conclusion

The market remains sensitive to geopolitical developments, particularly regarding Iran. Investors are advised to stay informed as negotiations continue and economic indicators evolve.

Back to US Stocks Email alerts subscription
Informational only. Not investment advice.